Crystagen (EDG Peptide)

Crystagen is an experimental short-chain peptide associated with immune system and immune cell biology research. It is commonly described as a tripeptide with the sequence Glu-Asp-Gly (EDG).

In experimental research, Crystagen is investigated in connection with immune cell function, cellular proliferation and differentiation, immune signaling, and immune system homeostasis, providing a research tool for studying cellular and molecular mechanisms involved in immune regulation.

Research involving short bioregulatory peptides has also explored potential relationships with cytokine signaling, gene expression, protein synthesis, and intercellular communication, helping researchers investigate complex regulatory networks within the immune system.

Crystagen may also be of interest in experimental studies involving innate and adaptive immunity, immune-cell stress responses, and the tissue immune microenvironment.

Evidence involving Crystagen remains limited, particularly with respect to large-scale human clinical studies. Experimental findings should therefore not be interpreted as established immune-enhancing, anti-infective, anti-inflammatory, or therapeutic effects in humans.

Livraison standard offerte dès 50 $ vers les États-Unis, le Canada, le Mexique et l'Europe. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.